RxDoctor Payments Data

Lauren Stavroff

Physician Assistant · Muncie, INNPI 1861031593

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.3% of the total across 384 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,129, more than ten times the $19 reported in 2021. Among physician assistant clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,942in general payments, 2019–2025

Across 384 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$928
  • Novartis$574
  • Sun Pharmaceutical Industries Inc.$430
  • Galderma Laboratories, L.p.$426
  • Johnson & Johnson$408
  • Lilly USA, LLC$385
  • plus $3K from 20 others

What the payments were for

  • Food & beverage$5,84398%
  • Education$992%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,942 in reported general payments places this provider in the 95th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab54$208,712
SotyktuDeucravacitinib21$135,391
Clobetasol Propionate111$3,695
Fluorouracil15$1,120
Doxycycline Hyclate37$856
Ketoconazole55$852
Triamcinolone Acetonide64$636
Clindamycin Phosphate11$435
Hydroxychloroquine Sulfate17$283
Mupirocin32$221
Hydrocortisone16$101
Hydroxyzine Hcl12$100
Prednisone11$27

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
E.r. Squibb & Sons, L.L.C.Sotyktu$116$135,39121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Muncie

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →